India  
 
NewsR.in

Eli Lilly’s weight-loss pill meets target in key diabetes trial

FT.com Tuesday, 26 August 2025 ()
Results from US pharma group show oral drug reduced body weight by 10.5% on average
0
shares		ShareTweetSavePostSend
 

You Might Like


Related news from verified sources

Eli Lilly's Obesity Pill Shows Big Wins In Weight, Blood Sugar And Heart Risk Factors

 Eli Lilly and Co. (NYSE:LLY) on Tuesday released topline results from the Phase 3 ATTAIN-2 trial, evaluating oral orforglipron in adults with obesity or...
Upworthy

Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval

 Eli Lilly on Tuesday said its daily weight loss pill helped patients with obesity and Type 2 diabetes shed weight in a late-stage trial, meeting the study's main...
Upworthy